Molecular imaging with optical coherence tomography using ligand-conjugated microparticles that detect activated endothelial cells: Rational design through target quantification

Andrew Jefferson, Rohan S. Wijesurendra, Martina A. McAteer, Janet E. Digby, Gillian Douglas, Thomas Bannister, Francisco Perez-Balderas, Zsolt Bagi, Alistair C. Lindsay, Robin P. Choudhury

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

Objectives: Optical coherence tomography (OCT) is a high resolution imaging technique used to assess superficial atherosclerotic plaque morphology. Utility of OCT may be enhanced by contrast agents targeting molecular mediators of inflammation. Methods and results: Microparticles of iron oxide (MPIO; 1 and 4.5μm diameter) in suspension were visualized and accurately quantified using a clinical optical coherence tomography system. Bound to PECAM-1 on a plane of cultured endothelial cells under static conditions, 1μm MPIO were also readily detected by OCT. To design a molecular contrast probe that would bind activated endothelium under conditions of shear stress, we quantified the expression (basal vs. TNF-activated; moleculesμm -2) of VCAM-1 (not detected vs. 16±1); PECAM-1 (132±6 vs. 198±10) and E-selectin (not detected vs. 46±0.6) using quantitative flow cytometry. We then compared the retention of antibody-conjugated MPIO targeting each of these molecules plus a combined VCAM-1 and E-selectin (E+V) probe across a range of physiologically relevant shear stresses. E+V MPIO were consistently retained with highest efficiency (P<0.001) and at a density that provided conspicuous contrast effects on OCT pullback. Conclusion: Microparticles of iron oxide were detectable using a clinical OCT system. Assessment of binding under flow conditions recommended an approach that targeted both E-selectin and VCAM-1. Bound to HUVEC under conditions of flow, targeted 1 μm E + V MPIO were readily identified on OCT pullback. Molecular imaging with OCT may be feasible in vivo using antibody targeted MPIO.

Original languageEnglish (US)
Pages (from-to)579-587
Number of pages9
JournalAtherosclerosis
Volume219
Issue number2
DOIs
StatePublished - Dec 1 2011

Keywords

  • Inflammation
  • Microparticles
  • Molecular imaging
  • OCT

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Molecular imaging with optical coherence tomography using ligand-conjugated microparticles that detect activated endothelial cells: Rational design through target quantification'. Together they form a unique fingerprint.

  • Cite this

    Jefferson, A., Wijesurendra, R. S., McAteer, M. A., Digby, J. E., Douglas, G., Bannister, T., Perez-Balderas, F., Bagi, Z., Lindsay, A. C., & Choudhury, R. P. (2011). Molecular imaging with optical coherence tomography using ligand-conjugated microparticles that detect activated endothelial cells: Rational design through target quantification. Atherosclerosis, 219(2), 579-587. https://doi.org/10.1016/j.atherosclerosis.2011.07.127